Not Cleared or Approved For Commercial Use in USA
Squid is indicated in the embolization of lesions in the peripheral and neurovasculature, including arteriovenous malformations and hypervascular tumours.
SQUID, liquid embolic agent intended for the embolisation of lesions in the peripheral and neurovasculature, including arteviovenous malformations and hypervascular tumours. Class III CE0297 in compliance with Medical Device Directive (MDD 93/42/EEC amended by 2007/47/EC). Manufactured by EMBO-FLÜSSIGKEITEN A.G. Carefully read the instructions for use before use.First CE marking: 2012.